In 65 patients with chronic rhinitis, CO2 laser posterior nasal neurolysis reduced rTNSS more than sham at 3 months (-4.7 vs -2.6); the ≥30% responder rate was not significantly higher (81.4% vs 63.6%). Adverse events were minimal.
RCTn = 65
Liao et al. Effect of Laser Posterior Nasal Neurolysis for the Treatment of Chronic Rhinitis: A Randomized Controlled Trial